Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
The Pending NDC and Bar Code Rule: Distributor Perspectives
The FDA has proposed an amendment to its regulations to adopt a uniform, 12-digit format for the NDC. In part two of this series, HDA’s Senior Director, Industry Relations, Tim Stearns discusses the NDC and bar code proposed amendments and analyzes distributors' comments.
New HDA Resources Available: Recall Guidelines and Standard Product Form
Earlier this month, HDA published two new resources for supply chain stakeholders to ensure the proper handling of new products moving through the supply chain and removal of products that are recalled or need to be withdrawn.
HDA Dialogue Explores DE&I Efforts In the Distribution Sector
Discussions surrounding diversity, equity and inclusion (DE&I) are critically important to the healthcare distribution industry as this work ultimately strengthens the industry’s ability to deliver safe, affordable and efficient healthcare to patients across the nation. Earlier this month, HDA hosted a virtual discussion with four industry leaders who are fostering belonging within their organizations.
HDA Statement on FDA Approval of Florida’s Prescription Drug Importation Plan
Healthcare Distribution Alliance (HDA) President and CEO Chip Davis released a statement regarding the Food and Drug Administration’s (FDA) decision to authorize the Florida Agency for Health Care Administration’s drug importation program under section 804 of the Federal Food, Drug, and Cosmetic Act.